We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
ASX healthcare shares are higher in early trading on Tuesday, with the S&P/ASX 200 Health Care I...
Read ArticleRespiri (ASX:RSH) has announced a binding agreement to acquire the business and assets of Orb Health...
Read ArticleASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results...
Read ArticleThe S&P/ASX 200 fell 1.3% in October with small cap companies outperforming S&P Dow Jones I...
Read ArticleHealthcare company Respiri (ASX: RSH) delivered strong growth in patient enrolments during the three...
Read ArticleTelix Pharmaceuticals’ brain cancer diagnostic could leapfrog over its kidney cancer assay to be it...
Read ArticleASX 200 hits record highs fuelled by Wall Street rally Tech and iron ore stocks lead gains Tyro...
Read ArticleCancer drug developer Chimeric Therapeutics eyes minimum $5 million raising ‘The next Telix’, Clari...
Read ArticleASX gains as energy and mining stocks rally Arcadium Lithium surges after Rio acquisition, while...
Read ArticleHealthcare stocks are doing relatively well globally in 2024 The sector could see more recovery as...
Read ArticleMedical technology specialist Respiri (ASX: RSH) has once again displayed the diversity of its busin...
Read Article‘Wheezo’ maker Respiri says a new US deal will help to propel the company to cash-flow break even b...
Read ArticleASX up on Thursday, tech stocks rise boosted by NextDC Wodside Energy drops due to downgrade and o...
Read ArticleASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing;...
Read ArticleANDHealth says the Covid-19 pandemic triggered far-reaching changes to Australia’s health system an...
Read ArticleS&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expec...
Read ArticleThe EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-l...
Read ArticleThe ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biot...
Read ArticleS&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biot...
Read ArticleResearch shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase th...
Read ArticleASX 200’s rally was driven mainly by gold/silver and iron ore stocks Gold prices hit record high as...
Read ArticleASX Health sector was in correction territory in April Why is the health sector different from othe...
Read ArticleAsthma affects hundreds of millions of people globally While inhalers are effective, people are not...
Read ArticleASX to lift on the back of Nasdaq rally US stocks rose on Friday as big techs reported solid res...
Read ArticleThere’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to c...
Read ArticleASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essenti...
Read ArticleViking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on p...
Read ArticleThe ASX benchmark has ended Wednesday higher after positive inflation data 7 of 11 sectors in the g...
Read ArticleXi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for t...
Read ArticleNews relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD f...
Read ArticleDigital human developer Unith (ASX:UNT) posts 25 per cent lift in revenue for Q1 FY24 At the quar...
Read ArticleMarjan Mikel – CEO – Respiri (ASX:RSH) offers the only remote patient monitoring program with remo...
Read ArticleL’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supr...
Read ArticleResearch reports on ASX-listed companies, to download in full. **** –Actinogen Medical ((ACW)) by Ed...
Read ArticleThe FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergenc...
Read ArticleEarnings reports dominated headlines in August Despite solid results from ASX healthcare giants, th...
Read ArticleAustralian biotech has attracted US investments in the last five years Among ASX stocks to get fund...
Read ArticleBiotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two g...
Read ArticleThe benchmark has sagged to -0.24% to close out the week with a world-weary sigh. Falling crude pr...
Read ArticleLocal markets have pedalled furiously since lunch to bring the benchmark to +0.35%. CBA posts recor...
Read ArticleA late surge from InfoTech pushed the benchmark to close at +0.07% InfoTech out front on +1.75%, ah...
Read ArticleThe end of pandemic and higher rates have subdued biotech market But there are signs now the sector...
Read ArticleResearch reports on ASX-listed companies, to download in full. **** -Amaero International ((3DA)) by...
Read ArticleWhilst the prevalence of Artificial intelligence has boosted the US-tech sector, with the likes of N...
Read ArticleResearch reports on ASX-listed companies, to download in full. **** –Actinogen Medical ((ACW)) by Ed...
Read ArticleBrisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “gam...
Read ArticleShareCafeRespiri (ASX:RSH) – Webinar Presentation Marjan Mikel, CEO and Brian Leedman, Non-Executiv...
Read ArticleResearch reports on ASX-listed companies, to download in full. **** –AFT Pharmaceuticals ((AFP)) – E...
Read ArticleSmall cap health stocks are not known to pay dividends But there’s a handful of such stocks on the...
Read ArticleBiotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We...
Read ArticleAfter a feeble start, the benchmark has rallied to close at +0.1% Newcrest and Newmont shake hands...
Read ArticleResearch reports on ASX-listed companies, to download in full. –Actinogen Medical ((ACW)) by Edison...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleThe ASX got an Data Nerd Bailout when the ABS dropped happy-ish CPI data The benchmark recovers fro...
Read ArticleThe ASX climbed 0.4% today after investors threatened it with a stick Mt Monger (ASX:MTM) wins the...
Read ArticleRespiri (RSH) becomes the first Australian company to have its medical device receive reimbursement...
Read ArticleThe FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have g...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticleRespiri (RSH) begins enrolling patients with chronic obstructive pulmonary disease (COPD) in its whe...
Read ArticleAfter yesterday’s pre-Chrimbo spend-up, SPI Futures are down 66 points (-0.38%) this morning, threat...
Read ArticleThe long and short of 2022 is that it was a frustrating period for the Australian biotech sector but...
Read ArticleRespiri’s wheezo RPM will be installed in New Mexico, USA Beamtree signs new distributor Bionomics...
Read ArticleRespiri (RSH) secures an additional primary care practice in New Mexico, US, for its wheezo remote p...
Read ArticleRespiri (RSH) begins onboarding patients in the short wheezo remote patient monitoring (RPM) pilot p...
Read ArticleRespiri (RSH) has secured its first primary care specialty practice in Georgia, USAs such, the compa...
Read ArticleASX 200 down -0.4% Small cap index loses -1.7% Way2VAT: killing it in the VAT space The small cap...
Read ArticleThe US FDA conditionally approved Anteris’ DurAVR system Respiri partners with a leading US cardiac...
Read ArticleThe ASX is set to end its four-day winning streak and slip on Monday Wall Street finished mixed aft...
Read ArticleASX health stocks have been out of favour this year with rotation away from growth to value sector...
Read ArticleRespiri’s (RSH) wheezo device and remote patient monitoring (RPM) solution have been selected by Min...
Read ArticleASX 200 halves gains on the run home Small cap index closes about 0.7% higher Tinkler takes more J...
Read ArticleWe take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks fr...
Read ArticleRespiri (RSH) establishes a Philippine-based Company Centre of Digital Innovation Excellence followi...
Read ArticleASX 200 down 1.6% Small caps short 1.3% Real Estate stocks hit ahead of FOMC meet The benchmark...
Read ArticleThe ASX 200 is vacillating Small caps are down over 1.3% Demetallica is a great name and it’s up 40...
Read ArticleOpyl has a new experienced chairman to lead the company into its next stage of growth on the back of...
Read ArticleThe ASX200 is down 0.24% dragged down by the tech sector Eight out of eleven sectors were lower, wi...
Read ArticleRespiri gives update on US market Screening results from 19 of Emyria’s MDMA compounds have been re...
Read ArticleHeraMed signs US deal worth $500k Pregnancy medtech specialist, HeraMed (ASX:HMD), was up over 20% t...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleKing’s College, London (KCL) receives a National Institute for Health Research (NIHR) funded UK pae...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleLiterally every sector had a red month, but mining was the worst PayGroup gets surprise $120m takeo...
Read ArticleTech leads losses on local markets ASX 200 gives away early gains, XEC dives more than 1% again BN...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleHealth technology company Respiri (ASX: RSH) has unveiled a $1.5 million capital raising as it fast-...
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleeHealth company Respiri (RSH) enters a trading halt ahead of a capital raise So far, there is no in...
Read ArticleHalo Technologies (HAL) shares have plunged 27.5 per cent since its ASX debut yesterday. The list...
Read ArticleThe healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak mark...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleAsthma management specialist Respiri (ASX: RSH) has signed a deal with US boutique firm EAS Advisors...
Read ArticleRespiri Limited (RSH) announces its first remote patient monitoring (RPM) pilot program involving i...
Read ArticleClinuvel releases positive preliminary results from pilot study Cann’s Mildura cannabis facility is...
Read ArticleRespiratory health management specialist Respiri (ASX: RSH) has launched its first reimbursed remote...
Read ArticleASX to fall, Nasdaq shaves another 2% Wall Street was mainly lower overnight, as the tech heavy Nasd...
Read ArticleFor now, all roads for ASX shares still lead back to the Russia-Ukraine war. And today investors hit...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticlePeter Switzer talks with Respiri (RSH) CEO, Marjan Mikel.
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleRespiri (RSH) signs a second, five-year, non-exclusive distribution and marketing agreement with Ac...
Read ArticleRespiri (RSH) secures a second order for Wheezo from mTelehealth Respiri has teamed up with mTelehe...
Read ArticleThe ASX 200 Health Index (XHJ) and the benchmark ASX 200 are trading flat today. Proteomics advances...
Read ArticleAt the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, be...
Read ArticleThe Respiri Ltd (ASX: RSH) share price leapt 14% to 6.5 cents in early trading this morning. This c...
Read ArticleRespiri (RSH) signs a five-year non-exclusive distribution and marketing deal with US-based remote...
Read ArticleIt’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 los...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleSummary Now Respiri’s Wheezo to be sold across pharmacies in Australia Value rises across DEXUS...
Read ArticleSummary The ASX 200 ended lower by 43.70 points or 0.60% at 7,298.50, led by losses in health ca...
Read Article23 Jun 2021 - A snapshot of notable stock news for the hour, featuring ikeGPS Group, Wide Open Agric...
Read Article23 Jun 2021 - Respiri (ASX:RSH) has announced the commencement of sales of its wheezo asthma-managem...
Read ArticleThe Respiri Ltd (ASX: RSH) share price is racing higher today after the company announced the addit...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleWall Street rebounds as Nasdaq resets record high All three major US benchmarks rose overnight, as i...
Read ArticleFertoz Ltd (ASX:FTZ) topped the pops with a red hot 14-day RSI of 93 after two massive days to finis...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleSummary Drug development and clinical services company Emyria has obtained Class IIa TGA registr...
Read ArticleThe ASX had a solid start to the week, gaining over 1 per cent and hitting a record high. The ASX 20...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleLast year's pandemic put the focus firmly on telehealth services providers, but share prices have de...
Read ArticleSummary Respiri Limited has partnered with Australia’s largest pharmacy network, TerryWhite Chem...
Read ArticleThe Respiri Ltd Fully Paid Ord. Shrs (ASX: RSH) share price has rocketed 18.2% higher at the market...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleWall Street mixed as iron ore climbs to record high Wall Street moved modestly overnight. The Dow Jo...
Read ArticleSummary With the current emergency, it is anticipated that telehealth or telemedicine could be t...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at th...
Read ArticleSource: DG PhotoStock, Shutterstock Summary ASX-cannabis player Bod Australia has obtained a bi...
Read ArticleThis tiny MedTech company, Respiri Ltd [ASX:RSH] managed to quadruple its share price from a low 6 c...
Read ArticleRespiratory health technology company Respiri (ASX: RSH) is trialling a telehealth and remote patien...
Read ArticleThe company’s flagship product Wheezo has received US FDA clearance, with a UK launch scheduled for...
Read ArticleDays after obtaining Food and Drug Administration approval for sales of its wheezo device in the US,...
Read ArticleRespiri Ltd (ASX: RSH) shares were on the move this morning after the company announced it will be...
Read ArticleAccording to CEO Marjan Mikel, “The regulatory clearance of wheezo and our App in the United...
Read ArticleGlobal stock markets dipped Stock markets dipped globally on fears over a potential third lockdown i...
Read ArticleRespiri (ASX:RSH) has just achieved a huge corporate milestone: its wheeze-detecting device has been...
Read ArticleSource: create jobs 51, Shutterstock Summary MGC Pharmaceuticals has received approval from the...
Read ArticleWheezo device and app technology developer, Respiri (ASX: RSH) has received the greenlight from the...
Read ArticleThe Respiri Ltd (ASX: RSH) share price is on watch today after the company advised it has received...
Read ArticleSmall caps have dipped slightly, while their larger peers have gained. The Small Ordinaries index fe...
Read ArticleSmall caps have closed lower today, but they finished the week in the green for a second week in a r...
Read ArticleSource: mstanley, Shutterstock On Friday, the market opened lower however, the bulls managed to pus...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticleSpecial Report: Asthma is the fourth most-prevalent non-communicable disease in the world, killing a...
Read ArticleRespiri (ASX:RSH) is taking a big step forward with an agreement for its Pharmacy Catalyst members t...
Read ArticleSummary Respiri Limited announced that Pharmacy Catalyst members to provide support to sales of...
Read ArticleRespiratory health focused Respiri (ASX: RSH) has bedded-in support for its wheezo device and platfo...
Read ArticleZip Co Ltd (ASX: Z1P) shares struggled in the second half of 2020 despite the company’s strong grow...
Read ArticleSpecial Report: Respiratory health company Respiri has entered into a sales and marketing partnershi...
Read ArticleRespiratory health technology company Respiri (ASX: RSH) has announced a new sales and marketing par...
Read ArticleImmutep Limited (ASX: IMM) announced that its Chinese partner, EOC Pharma, will begin a new Phase II...
Read ArticleSpecial Report: Respiri’s deal with Cipla will allow it to boost distribution of its wheezo asthma m...
Read ArticleDemand for Respiri’s (ASX: RSH) wheezo asthma management device has continued to grow following the...
Read ArticleSummary Despite the challenges imposed by COVID-19, Volpara Heath delivered a substantial 38% re...
Read ArticleThree months after announcing the start of a co-major partnership with Carlton Football Club, health...
Read ArticleIt’s been a bumpy road of development for Respiri Ltd [ASX:RSH]. Today though, with an early gain of...
Read ArticleWith Respiri’s (ASX: RSH) stage launch of wheezo across select Australian pharmacies and online unde...
Read ArticleSpecial Report: Respiri Limited’s (ASX:RSH) expects its gross product margins for its wheezos to be...
Read ArticleRespiratory health management company Respiri (ASX: RSH) has updated the market regarding the prelim...
Read ArticleSummary ASX-listed eHealth SaaS Company Respiri Limited filed for an additional patent applicatio...
Read ArticleRespiratory-focused eHealth company Respiri (ASX: RSH) has filed an additional patent application ba...
Read ArticleSpecial Report: Melbourne-based asthma assessment company Respiri is taking steps to protect its com...
Read ArticleOpenpay Group Ltd (ASX: OPY) has achieved record growth in the first quarter of FY21, potentially o...
Read ArticleSpecial Report: Respiri Limited has completed an oversubscribed $12.5 million to fund the launch of...
Read ArticleSummary Respiri Limited announced the successful completion of a $12.5 million share placement....
Read ArticleeHealth company Respiri (ASX: RSH) has completed a $12.5 million capital raising targeted at the com...
Read ArticleSaaS health company Respiri was cap in hand in front of investors on Wednesday morning, as it gears...
Read ArticleAt time of writing, the Respiri Ltd [ASX:RSH] share price is up 4.55%, trading at 23 cents. The Melb...
Read ArticleThe Respiri Limited (ASX: RSH) share price is up 6.82% to 23.5 cents in early afternoon trading. Th...
Read ArticleHealth technology company Respiri (ASX: RSH) has engaged Entech Electronics to manufacture its “grou...
Read ArticleASX telehealth stocks have had a solid six months, gaining 25 per cent, but there are warnings more...
Read ArticleThe share price of medical technology company Respiri Ltd [ASX:RSH] has pushed higher today thanks t...
Read ArticlePreliminary results of a clinical study involving the wheezo asthma management platform made by eHea...
Read ArticleSpecial Report: Respiri remains on track to commercialise its wheezo asthma detection device before...
Read ArticleSpecial Report: Respiri ‘kicks a ton’ with new Carlton Football Club AFLW team partnership. Ehealth...
Read ArticleA day after publishing its full year accounts, eHealth company Respiri (ASX: RSH) has tentatively se...
Read ArticleIt’s been a mixed year for Respiri Ltd [ASX:RSH]. With markets gripped by the COVID-19 pandemic, sha...
Read ArticleeHealth company Respiri (ASX: RSH) has taken another step towards growing sales of its wheezo device...
Read ArticleStockTalk is a Stockhead video series featuring a roundtable of experts discussing a new investment...
Read ArticleeHealth Software-as-a-Service (Saas) company Respiri (ASX: RSH) has updated the market with news it...
Read ArticleTelehealth use has only continued to increase as COVID-19 wore on throughout May and June. Both list...
Read ArticleeHealth technology developer and maker of the wheezo device, Respiri (ASX: RSH) has published interi...
Read ArticleSpecial Report: Respiratory health company Respiri has signed on to Zip Money, a move it expects to...
Read ArticleRespiri (RSH) has signed a merchant services agreement with buy now, pay later giant Zip Co's (Z1P)...
Read ArticleWheezo developer Respiri’s (ASX: RSH) commercialisation path will accelerate even further after the...
Read ArticleThe Respiri Ltd (ASX: RSH) share price has today reached 52-weeks highs, following news that the eH...
Read ArticleFor those with existing respiratory illnesses, like asthma, it has been an even more challenging tim...
Read ArticleA quick wrap of the ASX’s key winners and losers on Friday, July 17. Data is taken after the market...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleSpecial Report: Respiri’s biggest ever sales agreement will yield significant sales in the first 12...
Read ArticleHealthcare technology developer Respiri (ASX: RSH) has signed an exclusive agreement with global res...
Read ArticleMedical technology is a broad field covering areas like biotechnology, pharmaceuticals, and informa...
Read ArticleSpecial Report: The agreement will see data from Respiri’s propriety wheezo technology collated to i...
Read ArticleeHealth software company Respiri (ASX: RSH) has unveiled a new partnership agreement with the Univer...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleSpecial Report: Respiratory ehealth business Respiri (ASX:RSH) has signed a deal to educate Australi...
Read ArticleRespiri (ASX: RSH) has collared a two-year definitive service agreement with the Pharmacy Guild of A...
Read ArticleParticipating in small cap raises is proving lucrative for investors, with shares in 47 small caps t...
Read ArticleRespiri (ASX: RSH) has topped up its cash reserves with $3.14 million after receiving “significant o...
Read ArticleSpecial Report: eHealth SaaS company Respiri has raised $3.14m in a heavily oversubscribed capital r...
Read ArticleAs we approach the middle of 2020, the investment environment surrounding the fallout from the COVID...
Read ArticleVidCon is Stockhead’s new virtual conference series, bringing you expert insights, panel discussions...
Read ArticleIt’s still a relatively difficult market to raise capital in, particularly at the junior end, but th...
Read ArticleSpecial Report: The deal with telehealth platform Practice Innovators International will give Respir...
Read ArticleRespiratory health management company Respiri (ASX: RSH) has entered into commercial discussions wit...
Read ArticleShares in Respiri Limited (ASX:RSH), an eHealth SaaS company supporting respiratory health managemen...
Read ArticleRespiri (ASX: RSH) has expanded the market for its wheezo technology after announcing a partnership...
Read ArticleAustralian biotech Genetic Signatures’ (ASX:GSS) is now able to start selling its recently developed...
Read ArticleStock Talk is a new Stockhead video series featuring a roundtable of experts discussing a new invest...
Read ArticleDespite March being a tough month to raise capital for ASX small caps, the money was still flowing f...
Read ArticleThe COVID-19 pandemic is making capital harder to come by for businesses across the board. But liste...
Read ArticleThe coronavirus-induced market carnage of the last few weeks has rattled plenty of investor nerves....
Read ArticleRespiratory focused SaaS company Respiri Limited (ASX: RSH) has experienced inbound demand for its w...
Read ArticleJatenergy (ASX:JAT) shares are surging after the company said it booked record sales and revenue in...
Read ArticleInvestment bank Lazard believes shareholder activism is going to become more rife in future. Shareho...
Read ArticleHealthcare technology developer Respiri (ASX: RSH) has revealed that the company has received the hi...
Read ArticleAir pollution is a growing problem that in recent days has reached our own backyard. Because of the...
Read ArticleWe hate to sound like an old school report, but it’s been a year of steady and solid progress for th...
Read ArticleJames Dean is returning to the silver screens after a six and a half decade absence. The Rebel Witho...
Read ArticleIn a submission to the aged care royal commission, Queen of Pain Prof Jennifer Abbey presented a har...
Read Article09 Oct 2019 - Respiri (ASX:RSH) CEO Mario Gattino will be leaving the medical technology company.
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleVillage Roadshow Village Roadshow Limited (ASX: VRL) is a communication service sector company, w...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
